These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 8882671)

  • 41. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.
    van den Berg CH; Smit C; Bakker M; Geskus RB; Berkhout B; Jurriaans S; Coutinho RA; Wolthers KC; Prins M
    Eur J Epidemiol; 2007; 22(3):183-93. PubMed ID: 17334821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevalence of HIV infection among drug users in Zuid-Limburg].
    Wiessing LG; Houweling H; Meulders WA; Cerdá E; Jansen M; Sprenger MJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1936-40. PubMed ID: 7477534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.
    Lidman C; Norden L; Kåberg M; Käll K; Franck J; Aleman S; Birk M
    Scand J Infect Dis; 2009; 41(9):679-84. PubMed ID: 19521924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevalence of HIV and HCV among injecting drug users (IDUs) in Yunnan, China].
    Li D; Zheng X; Zhang G
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):74-5. PubMed ID: 7522968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HIV/HCV/HBV infections and drug-related risk behaviours amongst IDUs recruited through peer-driven sampling in Iran.
    Zamani S; Radfar R; Nematollahi P; Fadaie R; Meshkati M; Mortazavi S; Sedaghat A; Ono-Kihara M; Kihara M
    Int J Drug Policy; 2010 Nov; 21(6):493-500. PubMed ID: 20483578
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning.
    Wand H; Spiegelman D; Law M; Jalaludin B; Kaldor J; Maher L
    Addiction; 2009 Dec; 104(12):2049-56. PubMed ID: 19804463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in the injecting risk behaviour of injecting drug users in London, 1990-1993.
    Hunter GM; Donoghoe MC; Stimson GV; Rhodes T; Chalmers CP
    AIDS; 1995 May; 9(5):493-501. PubMed ID: 7639975
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of hepatitis B and C and HIV infections among problem drug users in Luxembourg: self-report versus serological evidence.
    Origer A; Schmit JC
    J Epidemiol Community Health; 2012 Jan; 66(1):64-8. PubMed ID: 20889592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence and correlates of hepatitis C virus (HCV) infection and HCV-HIV co-infection in a community sample of gay and bisexual men.
    Myers T; Allman D; Xu K; Remis RS; Aguinaldo J; Burchell A; Calzavara L; Swantee C
    Int J Infect Dis; 2009 Nov; 13(6):730-9. PubMed ID: 19186090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.
    Cannon MJ; Dollard SC; Smith DK; Klein RS; Schuman P; Rich JD; Vlahov D; Pellett PE;
    N Engl J Med; 2001 Mar; 344(9):637-43. PubMed ID: 11228278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection].
    Cheng H
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Edinburgh drug users: are they injecting and sharing less?
    Peters AD; Reid MM; Griffin SG
    AIDS; 1994 Apr; 8(4):521-8. PubMed ID: 8011257
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV in injecting drug users in Edinburgh: prevalence and correlates.
    Davies AG; Dominy NJ; Peters A; Bath GE; Burns SM; Richardson AM
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):399-405. PubMed ID: 7882106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
    Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
    J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.